Bone mass in Parkinson's disease: a study with three methods
- PMID: 8661963
- DOI: 10.1007/BF02509377
Bone mass in Parkinson's disease: a study with three methods
Abstract
Recent reports suggest the presence of osteopenia in a high percentage of patients with Parkinson's disease (PD). These data contrast with previous reports of our group, perhaps due to the different methods used. We studied bone mass in 52 PD patients (28 males, 24 females) and in 80 age- and sex-matched controls (40 males, 40 females) who had no other disease that could affect bone mass. We measured the totally body bone mineral content (TBBMC) and the ultrasound bone velocity (UBV) of transmission in phalanx, and performed metacarpal radiogrammetry with computerized radiography (CCT). We also measured serum levels of total alkaline phosphatase and tartrate-resistant acid phosphatase, which were significantly increased in PD patients compared with controls (P < 0.0001). TBBMC was significantly lower in males (P < 0.05) and females (P < 0.05) with PD with respect to their controls. CCT did not differ significantly between the study groups. UBV was significantly lower in males with PD (P < 0.005), but similar in female PD and controls. These data suggest that the changes reported in bone mass in PD patients can depend on the sex and the study methods. We only found severe osteopenia in one male (3.6%) and five females (20.8%) with PD according to z-score. Only in women was no relationship found between TBBMC and severity of PD.
Similar articles
-
Total and regional bone mass and biochemical markers of bone remodeling in metastatic prostate cancer.Prostate. 1998 Jun 1;35(4):243-7. doi: 10.1002/(sici)1097-0045(19980601)35:4<243::aid-pros2>3.0.co;2-h. Prostate. 1998. PMID: 9609546
-
Age-related changes of serum tartrate-resistant acid phosphatase 5b and the relationship with bone mineral density in Chinese women.Acta Pharmacol Sin. 2008 Dec;29(12):1493-8. doi: 10.1111/j.1745-7254.2008.00890.x. Acta Pharmacol Sin. 2008. PMID: 19026169
-
Bone mineral density measured by dual X-ray absorptiometry in Spanish patients with insulin-dependent diabetes mellitus.Calcif Tissue Int. 1996 May;58(5):316-9. doi: 10.1007/BF02509378. Calcif Tissue Int. 1996. PMID: 8661964
-
Prediction of bone mass in renal hyperparathyroidism by newly developed bone metabolic markers: evaluation of serum levels of carboxy-terminal pyridinoline cross-linked telopeptide of type I collagen and carboxy-terminal propeptide of type I procollagen.World J Surg. 1996 Sep;20(7):753-6; discussion 756-7. doi: 10.1007/s002689900114. World J Surg. 1996. PMID: 8678946
-
Phalangeal quantitative ultrasound technology and dual energy X-ray densitometry in patients with primary hyperparathyroidism: influence of sex and menopausal status.Osteoporos Int. 2003 Jul;14(7):602-8. doi: 10.1007/s00198-003-1407-2. Epub 2003 Apr 29. Osteoporos Int. 2003. PMID: 12730752
Cited by
-
Prevalence and risk factors of osteoporosis in patients with Parkinson's disease.Rheumatol Int. 2008 Oct;28(12):1205-9. doi: 10.1007/s00296-008-0632-6. Epub 2008 Jul 1. Rheumatol Int. 2008. PMID: 18592245
-
Bone health in Parkinson's disease: a systematic review and meta-analysis.J Neurol Neurosurg Psychiatry. 2014 Oct;85(10):1159-66. doi: 10.1136/jnnp-2013-307307. Epub 2014 Mar 11. J Neurol Neurosurg Psychiatry. 2014. PMID: 24620034 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical